Boston Scientific EVP Joseph M. Fitzgerald Buys $3.0M Stock

What Happened
Joseph Michael Fitzgerald, EVP & Group President, Cardiology at Boston Scientific (BSX), acquired 64,198 shares of BSX common stock on July 31, 2026 at $46.73 per share, a total transaction value of approximately $2,999,973. This was a purchase (acquisition) of company stock.

Key Details

• Transaction date: 2026-07-31; Filing date (Form 4): 2026-08-03 (timely filing).
• Shares acquired: 64,198 at $46.73 each; total ≈ $2,999,973.
• Method: Discretionary transaction made pursuant to an election to rebalance holdings under the company’s 401(k) Retirement Savings Plan (per footnote F1).
• Holdings after transaction: The filing references the most current 401(k) plan balance (footnote F2); no total post-transaction beneficial ownership number for outside holdings is provided in the supplied data.
• Beneficial ownership note: The reporting person disclaims beneficial ownership of shares held by his child (footnote F3).

Context
This was a 401(k) plan rebalancing rather than an open-market trade or option exercise. Such plan-directed purchases reflect allocation changes within retirement accounts and are routine; purchases can be interpreted as a positive signal but do not, by themselves, prove insider sentiment. No options exercise, award, or sale was reported in this filing.